Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SIthis companyShoulder Innovations, Inc.	$20.03	-7.3×	2.1×	6.23×	-7.64×	-723.5%	76.5%	-55.6%	-85.3%	-28.7%	-16.9%	-12.2%	0.11×	0.32×	-375.67×	11.07×	0.0%	2	8.22	1	C-
AARDAardvark Therapeutics, Inc. Common Stock	$1.33	-4.97×	2.69×	0×	-4.17×	71.6%	0.0%	0.0%	0.0%	-54.0%	-58.6%	-18.9%	0×	0.81×	0×	10.61×	0.0%	1	-1.98	3	B-
ASMBAssembly Biosciences, Inc.	$21.12	-61.84×	1.84×	5.27×	-54.31×	-382.4%	99.8%	-16.8%	-8.5%	-3.0%	-5.8%	-10.8%	0.01×	9.31×	0×	5.22×	0.0%	2	7.22	2	B-
ENTAEnanta Pharmaceuticals, Inc.	$11.46	-3.12×	3.95×	3.91×	-5.99×	-669.1%	93.0%	-130.7%	-125.4%	-126.5%	-31.4%	-12.6%	3.11×	-2.38×	-11.11×	4.21×	0.0%	3	-0.92	1	C-
INGNInogen, Inc.	$5.98	-7.91×	0.95×	0.52×	-35.43×	-203.4%	47.6%	-8.7%	-6.5%	-11.8%	-12.3%	-11.8%	0.09×	31.71×	0×	3.12×	0.0%	3	1.53	2	C
NAUTNautilus Biotechnolgy, Inc.	$2.35	-4.15×	1.57×	0×	-5.02×	-106.3%	0.0%	0.0%	0.0%	-37.6%	-35.7%	-21.1%	0.19×	-0.34×	0×	13.33×	0.0%	3	1.3	2	C
Peer median	—	-4.97×	1.84×	0.52×	-5.99×	-203.4%	47.6%	-8.7%	-6.5%	-37.6%	-31.4%	-12.6%	0.09×	0.81×	0×	5.22×	0.0%	3	1.3	2	—